Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soyeon Shim

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|June 4, 2024
EW-7197, transforming growth factor β inhibitor, combined with irreversible electroporation for improving skin wound in a rat excisional modelChu Hui Zeng, Jeon Min Kang, Song Hee Kim, et al.
Diabetes & Metabolism Journal|April 25, 2023
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic SteatohepatitisKyung Bong Ha, Eun Soo Lee, Na Won Park, et al.
Endocrinology and Metabolism (Seoul, Korea)|March 8, 2022
EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and InflammationKyung Bong Ha, Weerapon Sangartit, Ah Reum Jeong, et al.
Surgery|December 28, 2022
Different routes of administering EW-7197 versus EW-7197⋅HBr for preventing peritoneal adhesion in a rat modelChu Hui Zeng, Song Hee Kim, Jeon Min Kang, et al.
Journal of Medicinal Chemistry|July 7, 2022
Discovery of (<i>E</i>)-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic SteatohepatitisSoyeon Shim, Maddeboina Krishnaiah, Madhusudana Reddy Sankham, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancerJi Eun Lee, Pureunchowon Lee, Young-Chan Yoon, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|June 4, 2024
EW-7197, transforming growth factor β inhibitor, combined with irreversible electroporation for improving skin wound in a rat excisional modelChu Hui Zeng, Jeon Min Kang, Song Hee Kim, et al.
Diabetes & Metabolism Journal|April 25, 2023
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic SteatohepatitisKyung Bong Ha, Eun Soo Lee, Na Won Park, et al.
Endocrinology and Metabolism (Seoul, Korea)|March 8, 2022
EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and InflammationKyung Bong Ha, Weerapon Sangartit, Ah Reum Jeong, et al.
Surgery|December 28, 2022
Different routes of administering EW-7197 versus EW-7197⋅HBr for preventing peritoneal adhesion in a rat modelChu Hui Zeng, Song Hee Kim, Jeon Min Kang, et al.
Journal of Medicinal Chemistry|July 7, 2022
Discovery of (<i>E</i>)-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic SteatohepatitisSoyeon Shim, Maddeboina Krishnaiah, Madhusudana Reddy Sankham, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancerJi Eun Lee, Pureunchowon Lee, Young-Chan Yoon, et al.
Pageof 2